Nicotinamide Riboside Supplements Market, Global Outlook and Forecast 2023-2029

Report ID
39073
Publisher
Market Monitor Global
Published Date
03-Nov
Delivery Format
PDF
No of Report Page
115
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details
    This research report provides a comprehensive analysis of the Nicotinamide Riboside Supplements market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nicotinamide Riboside Supplements market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nicotinamide Riboside Supplements, challenges faced by the industry, and potential opportunities for market players.
    The global Nicotinamide Riboside Supplements market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nicotinamide Riboside Supplements market presents opportunities for various stakeholders, including Online Sales, Offline Sales. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nicotinamide Riboside Supplements market. Additionally, the growing consumer demand present avenues for market expansion.
    The global Nicotinamide Riboside Supplements market was valued at US$ 63 million in 2022 and is projected to reach US$ 106.7 million by 2029, at a CAGR of 7.6% during the forecast period.
    Key Features:
    The research report on the Nicotinamide Riboside Supplements market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
    Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nicotinamide Riboside Supplements market.
    Market Overview: The report provides a comprehensive overview of the Nicotinamide Riboside Supplements market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Capsule, Liquid), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
    Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nicotinamide Riboside Supplements market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nicotinamide Riboside Supplements market's trajectory.
    Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nicotinamide Riboside Supplements market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
    Market Segmentation and Forecast: The report segment the Nicotinamide Riboside Supplements market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
    Technological Trends: The report should highlight the key technological trends shaping the Nicotinamide Riboside Supplements market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
    Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nicotinamide Riboside Supplements market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
    Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nicotinamide Riboside Supplements, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
    Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nicotinamide Riboside Supplements market.
    Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
    Market Segmentation
    Nicotinamide Riboside Supplements market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
        Capsule
        Liquid
        Softgel
    Market segment by Application
        Online Sales
        Offline Sales
    Global Nicotinamide Riboside Supplements Market Segment Percentages, By Region and Country, 2022 (%)
        North America
            US
            Canada
            Mexico
        Europe
            Germany
            France
            U.K.
            Italy
            Russia
            Nordic Countries
            Benelux
            Rest of Europe
        Asia
            China
            Japan
            South Korea
            Southeast Asia
            India
            Rest of Asia
        South America
            Brazil
            Argentina
            Rest of South America
        Middle East & Africa
            Turkey
            Israel
            Saudi Arabia
            UAE
            Rest of Middle East & Africa
    Major players covered
        Thorne
        Codeage
        ProHealth Longevity
        ChromaDex
        HPN Nutraceuticals
        Cytoplan
        solodate
        Orgabay
        Rossylla
        Life Extension
        Aesticum
        ProHealth
        NOW
        Double Wood Supplements
        aSquared Nutrition
    Outline of Major Chapters:
    Chapter 1: Introduces the definition of Nicotinamide Riboside Supplements, market overview.
    Chapter 2: Global Nicotinamide Riboside Supplements market size in revenue and volume.
    Chapter 3: Detailed analysis of Nicotinamide Riboside Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
    Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
    Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
    Chapter 6: Sales of Nicotinamide Riboside Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
    Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
    Chapter 8: Global Nicotinamide Riboside Supplements capacity by region & country.
    Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
    Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
    Chapter 11: The main points and conclusions of the report.
    
  • Table Of Content
    1 Introduction to Research & Analysis Reports
        1.1 Nicotinamide Riboside Supplements Market Definition
        1.2 Market Segments
            1.2.1 Market by Type
            1.2.2 Market by Application
        1.3 Global Nicotinamide Riboside Supplements Market Overview
        1.4 Features & Benefits of This Report
        1.5 Methodology & Sources of Information
            1.5.1 Research Methodology
            1.5.2 Research Process
            1.5.3 Base Year
            1.5.4 Report Assumptions & Caveats
    2 Global Nicotinamide Riboside Supplements Overall Market Size
        2.1 Global Nicotinamide Riboside Supplements Market Size: 2022 VS 2029
        2.2 Global Nicotinamide Riboside Supplements Revenue, Prospects & Forecasts: 2018-2029
        2.3 Global Nicotinamide Riboside Supplements Sales: 2018-2029
    3 Company Landscape
        3.1 Top Nicotinamide Riboside Supplements Players in Global Market
        3.2 Top Global Nicotinamide Riboside Supplements Companies Ranked by Revenue
        3.3 Global Nicotinamide Riboside Supplements Revenue by Companies
        3.4 Global Nicotinamide Riboside Supplements Sales by Companies
        3.5 Global Nicotinamide Riboside Supplements Price by Manufacturer (2018-2023)
        3.6 Top 3 and Top 5 Nicotinamide Riboside Supplements Companies in Global Market, by Revenue in 2022
        3.7 Global Manufacturers Nicotinamide Riboside Supplements Product Type
        3.8 Tier 1, Tier 2 and Tier 3 Nicotinamide Riboside Supplements Players in Global Market
            3.8.1 List of Global Tier 1 Nicotinamide Riboside Supplements Companies
            3.8.2 List of Global Tier 2 and Tier 3 Nicotinamide Riboside Supplements Companies
    4 Sights by Product
        4.1 Overview
            4.1.1 By Type - Global Nicotinamide Riboside Supplements Market Size Markets, 2022 & 2029
            4.1.2 Capsule
            4.1.3 Liquid
            4.1.4 Softgel
        4.2 By Type - Global Nicotinamide Riboside Supplements Revenue & Forecasts
            4.2.1 By Type - Global Nicotinamide Riboside Supplements Revenue, 2018-2023
            4.2.2 By Type - Global Nicotinamide Riboside Supplements Revenue, 2024-2029
            4.2.3 By Type - Global Nicotinamide Riboside Supplements Revenue Market Share, 2018-2029
        4.3 By Type - Global Nicotinamide Riboside Supplements Sales & Forecasts
            4.3.1 By Type - Global Nicotinamide Riboside Supplements Sales, 2018-2023
            4.3.2 By Type - Global Nicotinamide Riboside Supplements Sales, 2024-2029
            4.3.3 By Type - Global Nicotinamide Riboside Supplements Sales Market Share, 2018-2029
        4.4 By Type - Global Nicotinamide Riboside Supplements Price (Manufacturers Selling Prices), 2018-2029
    5 Sights by Application
        5.1 Overview
            5.1.1 By Application - Global Nicotinamide Riboside Supplements Market Size, 2022 & 2029
            5.1.2 Online Sales
            5.1.3 Offline Sales
        5.2 By Application - Global Nicotinamide Riboside Supplements Revenue & Forecasts
            5.2.1 By Application - Global Nicotinamide Riboside Supplements Revenue, 2018-2023
            5.2.2 By Application - Global Nicotinamide Riboside Supplements Revenue, 2024-2029
            5.2.3 By Application - Global Nicotinamide Riboside Supplements Revenue Market Share, 2018-2029
        5.3 By Application - Global Nicotinamide Riboside Supplements Sales & Forecasts
            5.3.1 By Application - Global Nicotinamide Riboside Supplements Sales, 2018-2023
            5.3.2 By Application - Global Nicotinamide Riboside Supplements Sales, 2024-2029
            5.3.3 By Application - Global Nicotinamide Riboside Supplements Sales Market Share, 2018-2029
        5.4 By Application - Global Nicotinamide Riboside Supplements Price (Manufacturers Selling Prices), 2018-2029
    6 Sights by Region
        6.1 By Region - Global Nicotinamide Riboside Supplements Market Size, 2022 & 2029
        6.2 By Region - Global Nicotinamide Riboside Supplements Revenue & Forecasts
            6.2.1 By Region - Global Nicotinamide Riboside Supplements Revenue, 2018-2023
            6.2.2 By Region - Global Nicotinamide Riboside Supplements Revenue, 2024-2029
            6.2.3 By Region - Global Nicotinamide Riboside Supplements Revenue Market Share, 2018-2029
        6.3 By Region - Global Nicotinamide Riboside Supplements Sales & Forecasts
            6.3.1 By Region - Global Nicotinamide Riboside Supplements Sales, 2018-2023
            6.3.2 By Region - Global Nicotinamide Riboside Supplements Sales, 2024-2029
            6.3.3 By Region - Global Nicotinamide Riboside Supplements Sales Market Share, 2018-2029
        6.4 North America
            6.4.1 By Country - North America Nicotinamide Riboside Supplements Revenue, 2018-2029
            6.4.2 By Country - North America Nicotinamide Riboside Supplements Sales, 2018-2029
            6.4.3 US Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.4.4 Canada Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.4.5 Mexico Nicotinamide Riboside Supplements Market Size, 2018-2029
        6.5 Europe
            6.5.1 By Country - Europe Nicotinamide Riboside Supplements Revenue, 2018-2029
            6.5.2 By Country - Europe Nicotinamide Riboside Supplements Sales, 2018-2029
            6.5.3 Germany Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.4 France Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.5 U.K. Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.6 Italy Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.7 Russia Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.8 Nordic Countries Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.5.9 Benelux Nicotinamide Riboside Supplements Market Size, 2018-2029
        6.6 Asia
            6.6.1 By Region - Asia Nicotinamide Riboside Supplements Revenue, 2018-2029
            6.6.2 By Region - Asia Nicotinamide Riboside Supplements Sales, 2018-2029
            6.6.3 China Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.6.4 Japan Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.6.5 South Korea Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.6.6 Southeast Asia Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.6.7 India Nicotinamide Riboside Supplements Market Size, 2018-2029
        6.7 South America
            6.7.1 By Country - South America Nicotinamide Riboside Supplements Revenue, 2018-2029
            6.7.2 By Country - South America Nicotinamide Riboside Supplements Sales, 2018-2029
            6.7.3 Brazil Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.7.4 Argentina Nicotinamide Riboside Supplements Market Size, 2018-2029
        6.8 Middle East & Africa
            6.8.1 By Country - Middle East & Africa Nicotinamide Riboside Supplements Revenue, 2018-2029
            6.8.2 By Country - Middle East & Africa Nicotinamide Riboside Supplements Sales, 2018-2029
            6.8.3 Turkey Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.8.4 Israel Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.8.5 Saudi Arabia Nicotinamide Riboside Supplements Market Size, 2018-2029
            6.8.6 UAE Nicotinamide Riboside Supplements Market Size, 2018-2029
    7 Manufacturers & Brands Profiles
        7.1 Thorne
            7.1.1 Thorne Company Summary
            7.1.2 Thorne Business Overview
            7.1.3 Thorne Nicotinamide Riboside Supplements Major Product Offerings
            7.1.4 Thorne Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.1.5 Thorne Key News & Latest Developments
        7.2 Codeage
            7.2.1 Codeage Company Summary
            7.2.2 Codeage Business Overview
            7.2.3 Codeage Nicotinamide Riboside Supplements Major Product Offerings
            7.2.4 Codeage Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.2.5 Codeage Key News & Latest Developments
        7.3 ProHealth Longevity
            7.3.1 ProHealth Longevity Company Summary
            7.3.2 ProHealth Longevity Business Overview
            7.3.3 ProHealth Longevity Nicotinamide Riboside Supplements Major Product Offerings
            7.3.4 ProHealth Longevity Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.3.5 ProHealth Longevity Key News & Latest Developments
        7.4 ChromaDex
            7.4.1 ChromaDex Company Summary
            7.4.2 ChromaDex Business Overview
            7.4.3 ChromaDex Nicotinamide Riboside Supplements Major Product Offerings
            7.4.4 ChromaDex Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.4.5 ChromaDex Key News & Latest Developments
        7.5 HPN Nutraceuticals
            7.5.1 HPN Nutraceuticals Company Summary
            7.5.2 HPN Nutraceuticals Business Overview
            7.5.3 HPN Nutraceuticals Nicotinamide Riboside Supplements Major Product Offerings
            7.5.4 HPN Nutraceuticals Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.5.5 HPN Nutraceuticals Key News & Latest Developments
        7.6 Cytoplan
            7.6.1 Cytoplan Company Summary
            7.6.2 Cytoplan Business Overview
            7.6.3 Cytoplan Nicotinamide Riboside Supplements Major Product Offerings
            7.6.4 Cytoplan Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.6.5 Cytoplan Key News & Latest Developments
        7.7 solodate
            7.7.1 solodate Company Summary
            7.7.2 solodate Business Overview
            7.7.3 solodate Nicotinamide Riboside Supplements Major Product Offerings
            7.7.4 solodate Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.7.5 solodate Key News & Latest Developments
        7.8 Orgabay
            7.8.1 Orgabay Company Summary
            7.8.2 Orgabay Business Overview
            7.8.3 Orgabay Nicotinamide Riboside Supplements Major Product Offerings
            7.8.4 Orgabay Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.8.5 Orgabay Key News & Latest Developments
        7.9 Rossylla
            7.9.1 Rossylla Company Summary
            7.9.2 Rossylla Business Overview
            7.9.3 Rossylla Nicotinamide Riboside Supplements Major Product Offerings
            7.9.4 Rossylla Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.9.5 Rossylla Key News & Latest Developments
        7.10 Life Extension
            7.10.1 Life Extension Company Summary
            7.10.2 Life Extension Business Overview
            7.10.3 Life Extension Nicotinamide Riboside Supplements Major Product Offerings
            7.10.4 Life Extension Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.10.5 Life Extension Key News & Latest Developments
        7.11 Aesticum
            7.11.1 Aesticum Company Summary
            7.11.2 Aesticum Business Overview
            7.11.3 Aesticum Nicotinamide Riboside Supplements Major Product Offerings
            7.11.4 Aesticum Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.11.5 Aesticum Key News & Latest Developments
        7.12 ProHealth
            7.12.1 ProHealth Company Summary
            7.12.2 ProHealth Business Overview
            7.12.3 ProHealth Nicotinamide Riboside Supplements Major Product Offerings
            7.12.4 ProHealth Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.12.5 ProHealth Key News & Latest Developments
        7.13 NOW
            7.13.1 NOW Company Summary
            7.13.2 NOW Business Overview
            7.13.3 NOW Nicotinamide Riboside Supplements Major Product Offerings
            7.13.4 NOW Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.13.5 NOW Key News & Latest Developments
        7.14 Double Wood Supplements
            7.14.1 Double Wood Supplements Company Summary
            7.14.2 Double Wood Supplements Business Overview
            7.14.3 Double Wood Supplements Nicotinamide Riboside Supplements Major Product Offerings
            7.14.4 Double Wood Supplements Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.14.5 Double Wood Supplements Key News & Latest Developments
        7.15 aSquared Nutrition
            7.15.1 aSquared Nutrition Company Summary
            7.15.2 aSquared Nutrition Business Overview
            7.15.3 aSquared Nutrition Nicotinamide Riboside Supplements Major Product Offerings
            7.15.4 aSquared Nutrition Nicotinamide Riboside Supplements Sales and Revenue in Global (2018-2023)
            7.15.5 aSquared Nutrition Key News & Latest Developments
    8 Global Nicotinamide Riboside Supplements Production Capacity, Analysis
        8.1 Global Nicotinamide Riboside Supplements Production Capacity, 2018-2029
        8.2 Nicotinamide Riboside Supplements Production Capacity of Key Manufacturers in Global Market
        8.3 Global Nicotinamide Riboside Supplements Production by Region
    9 Key Market Trends, Opportunity, Drivers and Restraints
        9.1 Market Opportunities & Trends
        9.2 Market Drivers
        9.3 Market Restraints
    10 Nicotinamide Riboside Supplements Supply Chain Analysis
        10.1 Nicotinamide Riboside Supplements Industry Value Chain
        10.2 Nicotinamide Riboside Supplements Upstream Market
        10.3 Nicotinamide Riboside Supplements Downstream and Clients
        10.4 Marketing Channels Analysis
            10.4.1 Marketing Channels
            10.4.2 Nicotinamide Riboside Supplements Distributors and Sales Agents in Global
    11 Conclusion
    12 Appendix
        12.1 Note
        12.2 Examples of Clients
        12.3 Disclaimer
    
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
connect with us